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Abstract
Background: The cancer which appears in the mobile portion of the tongue is the most common neoplasm of the 
oral cavity. The objective of this study was to analyse oral tongue cancer epidemiology in a population of 610 
patients diagnosed between 1990 and 2008 and detailed in the Tumour Registry of the Madrid region. 
Material and Methods: A retrospective analysis based on the following variables provided in the Tumour Registry 
was achieved: age, gender, histology, stage, location, treatment. Descriptive and analytic statistics with these vari-
ables, using Pearson’s Chi-square test to study the relationship between the qualitative variables. 
Results: Patients’ mean age was 61.53±13.95 years, with a gender ratio of 2.09:1 (413 males vs 197 females). The 
lesion was mainly localized in the lateral border of tongue, with other sites (dorsal face, ventral face, lingual ton-
sil, contiguous sites, tongue NOS) represented at lower rates. Squamous cell carcinomas (94.9%) far outweighted 
other histologies (salivary gland tumours, soft tissue tumours, haematolymphoid tumours). 59% of the cases ap-
peared in localized stages, versus 35.2% in regional and 4.8% in distant stages. Surgery was the most frequently 
used treatment, followed by surgery in combination with radiotherapy. 
Conclusions: Oral tongue cancer is a disease of the elderly, with a male predominance. It mainly appears in its 
lateral border, localized squamous cell carcinomas representing the great majority of lingual neoplasms. 
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Introduction
Epidemiologists generally consider cancers of the 
tongue, gum, floor and other areas of mouth and phar-
ynx as a unique group called oral cancer. However, 
some differences exist between these cancers in epi-
demiological terms, the most common neoplasm of the 
oral cavity being the cancer which appears in the mobile 
portion of the tongue (1). It exclusively constitutes the 
category of tongue cancer in clinical terms, as tumours 
of its base, which behave differently, are considered 
oropharynx tumours. 
Although tongue cancer represents a health problem 
in certain countries of South-East Asia, where lately a 
significant increase in the incidence of the disease has 
been observed (2), an increasing number of incidents 
in Western countries such as the United States has also 
been detected.
Cancer deaths are reduced, first of all, through pri-
mary prevention - reducing incidence of the disease in 
the community - followed by better survival rates for 
patients through successful treatment. Therefore, all 
information concerning the survival of a patient diag-
nosed with cancer constitutes the most useful instru-
ment for the control of the disease, together with the 
data of incidence and mortality (3). In this context, 
hospital and population-based cancer registries are ex-
tremely important. Although these registry systems are 
designed with different objectives and methodologies, 
they complement each other and are equally essential. 
Patient and Methods
The studied population consists of 610 patients di-
agnosed with tongue cancer between 1990 and 2008, 
coming from the Database of the Central Registry of 
Tumours of the Autonomous Community of Madrid. 
In this database, “case” is defined as every patient with 
a diagnosed tumour whose behaviour code (fifth digit 
according to the third edition of WHO’s International 
Classification of Diseases for Oncology, ICD-O-3) is 
equal or superior to 2, and whose topographic code 
is C02, thus malignant neoplasms of the base of the 
tongue remain excluded. Only primary tumours have 
been included. Three variables of age have been dif-
ferentiated: “age in five-year periods”, “age in decades” 
and “under 65/65 or more years”. Tumour location and 
histology are codified according to the ICD-O-3. Due to 
the high number of histological groups given in the Tu-
mour Registry, the cases have been pooled on the basis 
of the main categories, according to the three first digits 
of their ICD-O-3 codification. In order to avoid data dis-
persion they were finally aggregated, resulting in two 
main groups: “Squamous cell carcinomas” and “Other 
histologies”. The SEER (Surveillance, Epidemiology 
and End Results) Staging System has been used for tu-
mour extension, considering for tongue cancer the fol-
lowing categories: localized (cancer confined to the mo-
bile tongue regardless of size), regional (cancer extend-
ing to regional lymph nodes), distant (cancer spreading 
beyond the tongue or having involved tissues beyond 
those immediately draining the tongue) and unknown. 
In case of lymphomas, those located in a lymphatic re-
gion above or below the diaphragm were considered lo-
calized; those affecting more than one lymphatic region 
but at only one side of the diaphragm were considered 
regional, and those affecting lymphatic regions at both 
sides were designated distant. Surgery (with or without 
neck dissection), radiotherapy, chemotherapy, pallia-
tives, surgery in combination with radiotherapy, chem-
otherapy with radiotherapy, surgery combined with 
chemo- and radiotherapy, and other treatments were the 
analysed therapeutic approaches.    
The population has been described according to the 
aforementioned variables. The relationship between 
qualitative variables was analysed using Pearson’s 
Chi-square test, at a signification level of p<0.05. Data 
analysis was performed using the ‘SPSS for Windows’ 
statistics software, version 19.0 (Statistical Package for 
the Social Sciences, SPSS Inc., Chicago, IL). The study 
was approved by the Institutional Ethics Committee 
(C.I. 12/225-E). 
Results
* Population features
At the moment of diagnosis, patients were aged between 
16 and 94 years, with a range of 77.88 years, 61.53±13.95 
years being the mean age. When grouping the patients in 
five-year periods, we observe that most of the cases di-
agnosed are upwards from 45 years of age. The group of 
patients aged 60-64 years comprises the highest number 
of cases (14.9%). Figure 1 represents the distribution of 
patients by decades. 55.2% of the patients were younger 
than 65 years and 44.7% were 65 or older. 
In our population, males were the most affected by the 
neoplasm (67.7%). The gender ratio was 2.09:1 (413 
males vs 197 females). The mean age among males at 
the time of diagnosis was 60±12.9 years; among fe-
males this was 64.7±15.4 years. When analysing the 
distribution by gender and age, we observe that most 
diagnoses among males take place before the age of 65, 
while among females most take place from that age on-
wards, these differences being statistically significant 
(p<0.001). 
* Tumour features
- Histology. Squamous cell carcinomas (SCC) represent 
the largest group, with 94.9% of the population. In ta-
ble 1 the cases have been grouped according to similar 
histological features in accordance with the ICD-O-3 
groups. SCCs stand out as the largest group, with a lim-
ited representation of the remaining neoplasms. For this 
reason they were pooled in a single category. For the 
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statistical analysis the variable “grouped histologies” 
was used for the two most characteristic histological 
forms in this organ: squamous cell carcinomas (94.9%) 
and other histologies (5.1%). The mean age in diagno-
sis among patients with SCC was 61.6±13.8 years, very 
similar to the mean age of patients who presented other 
histologies (59.1±15.4 years) (p>0.05). The predomi-
nance of SCC is easily seen through a frequency distri-
bution (Fig. 2). Thus, when evaluating the SCC evolu-
tion pattern, we observe that during the first decades 
of life its incidence is very limited. From 35 years on it 
starts to increase significantly, continuing up to 55-64 
years, the age of maximum incidence. From that mo-
ment on it begins to decrease. In contrast, the other his-
tologies show an undulating pattern which may be due 
to the complex collection of neoplasms in this group. 
Among males, SCCs represent the largest group with 
386 cases (93.5%), compared with 27 cases of other 
histologies (6.5%). Among females, the differences be-
tween groups are more significant, with 193 squamous 
cell carcinomas (98%) versus only 4 cases (2%) of other 
histologies (p<0.05).  
- Tumour location. Tongue cancer is localized in the 
lateral border of this organ in 46.4% of cases, with the 
remaining sites represented at lower rates: dorsal face 
6.1%, ventral face 4.9%, lingual tonsil 2.5%, contiguous 
sites 3.8%. However, an important proportion is repre-
sented by the NOS (Not Otherwise Specified) category 
(36.4%). When grouping the cases by location and gen-
der, the observed pattern is maintained, with a higher 
number of cases for every location among males. We 
find important differences between ventral tongue and 
lingual tonsil in the gender ratio (5:1 - 25 males vs 5 
females - and 14:1 - 14 males vs 1 female - respective-
ly) (p<0.05). The topographic or anatomic distribution 
varies according to the type of tumour. Thus, 46.6% of 
SCCs are settled in the border of the tongue, 6.2% in the 
dorsal face, 5.2% in the ventral face, and 1.4% in the 
lingual tonsil. The remaining histologies were observed 
in the border of the tongue in 41.9% of occasions, 22.6% 
in lingual tonsil and 3.2% in the dorsal face (p<0.001). 
In almost every anatomical site the localized stage pre-
dominates. In ventral tongue, 73.3% of neoplasms are 
localized, 26.7% are regional and there are no distant 
Fig. 1. Diagnosed cases by age group in decades according to the age grouping established by SEER.
Histologic group Frequency Percentage
Neoplasms and epitelial neoplasms 
NOS
15 2.4
Squamous cell carcinomas 579 94.9
Salivary gland tumours 6 0.9
Soft tissue tumours 1 0.1
Haematolymphoid tumours 9 1.4
Total       610        100.0
Table 1. Distribution of cases according to histological groups. 
Med Oral Patol Oral Cir Bucal. 2016 Nov 1;21 (6):e658-64.                                                                                                                                                                         Tongue cancer epidemiology
e661
ones. In the lateral border the localized (67.1%) and re-
gional (29.7%) stages are predominant. However, the 
lingual tonsil does not follow this pattern, as the region-
al stages (46.7%) exceed the localized ones (40%), and 
a relatively high percentage of cases in distant stages 
(13.3%) is observed. In the dorsal face (37 cases) we find 
the following distribution: 59% localized, 35.1% region-
al and 2.7% distant (p<0.01).                  
- Clinical stage of disease. At the time of diagnosis, 59% 
of the cases were in a localized and 35.2% a regional 
stage. In our population, only 4.8% of the tumours are 
distant (Fig. 3). Among younger patients, as well as 
among patients over 65, localized extension is the most 
frequent (54.9 vs 64%, respectively), followed by the 
regional and finally the distant extension. It should be 
noted that among patients under 65 years of age we find 
a higher percentage of cases in regional (39.2%, 132 
cases) as well as distant stages (5.6%, 19 cases) when 
compared to the older patients (30.4% regional, 3.7% 
distant) (p<0.05). As the stage progresses, the gender 
ratio increases. In localized stages the gender ratio is 
1.6:1 (225 males vs 135 females), in regional stages it is 
3.05:1 (162 vs 53) and in the distant ones, 6.25:1 (25 vs 
4) (p<0.001). This suggests that among women diagno-
sis is earlier. SCCs were mainly distributed in localized 
stages (58.9%), followed by regional (35.9%) stages, 
with only 4.1% presenting a distant stage.  
Similarly, the other neoplasms (lymphomas, adenomas) 
are mainly diagnosed in localized (61.3%) and regional 
(22.6%) stages, with 16.1% in distant stages (p<0.05). 
* Treatment features
The treatment options have been grouped according to 
the most frequent treatments, as described in Patients 
and methods, for the purpose of statistical analysis. The 
Fig.  2. Distribution of frequencies of age groups in decades in each histological group.
Fig. 3. Distribution of the stage at diagnosis, in percentages.
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result is shown in table 2. The first treatment option was 
surgery in 77.9% of cases and radiotherapy in 10.5%. 
When a second treatment was needed (37.4% of cases), 
radiotherapy was the selected option in 27.5% of cases. 
A total of 297 cases were treated by isolated surgery, 
and 52 by isolated radiotherapy.
The distribution of the most common therapeutic ap-
proaches used as the first therapeutic option by the dif-
ferent variables can be seen in table 3. In the lingual ton-
sil, 26.7% of the tumours were treated with a combina-
tion of chemotherapy and radiotherapy. The remaining 
therapeutic approaches are found in lower proportions. 
It should be noted when analysing the distribution of tu-
mour extensions in each therapeutic option, we observe 
that the patients surgically treated constitute the higher 
percentage of cases with localized extension (83.2%). 
Similarly, among patients treated with radiotherapy, the 
neoplasms in localized stages represent 67.3%. Patients 
who receive palliatives only present regional and dis-
tant stages. In the case of patients treated with chemo-
therapy, 28.6% were localized, 64.3% regional and 7.1% 
distant (p<0.001). 
Discussion
The Central Tumour Registry of the Data Exchange 
System of the Autonomous Community of Madrid (Sis-
tema de Intercambio de Datos de Cáncer, SIDC) is a 
hospital-based cancer registry. This means that every 
patient has been diagnosed and treated in hospital. Thus, 
there is a patient selection bias and it is not possible to 
calculate or predict incidences. These represent major 
limitations of our study. Although this does not affect 
the internal validity of the study, results are not trans-
ferable to the population.  Moreover, variables enabling 
the estimation of risk factors such as tobacco, alcohol, 
traumatisms, candidiasis, nutritional deficiencies, fam-
ily history, viral infections or poor oral hygiene are not 
registered. However, other information of interest, such 
as treatment, clinical follow-up (for survival studies, 
data not shown), histological diagnosis and extension, 
among others, is given by this type of registry. 
SCC of the oral cavity is rare in patients under 50 years, 
being basically a disease which appears in the sixth or 
seventh decade of life. The mean age of our population 
with tongue cancer, 61.53±13.95 years, was very similar 
Therapeutic approach Frequency Percentage
Surgery 297 48.7
Radiotherapy 52 8.5
Chemotherapy 14 2.3
Palliatives 22 3.6
Surgery + Radio. 122 20.0
Chemo. + Radio. 27 4.4
Surgery + Chemo. + Radio. 22 3.6
Other treatments 54 8.9
Total 610 100
Table 2. Therapeutic approach. 
<65 years
≥65 years
Surgery (43.9%)
Surgery (54.6%)
Surgery + Radio. (21.1%)
Surgery + Radio. (18.7%) p>0.05
Males
Females
Surgery (42.9%)
Surgery (60.9%) 
Surgery + Radio. (22%)
Surgery+ Radio. (15.7%) p<0.01
SCC
Other histologies
Surgery (49.1%)
Surgery (41.9 %)
Surgery + Radio. (20%)
Surgery + Radio. (19.4%) p<0.05
Localized
Regional
Distant
Surgery (68.6%)
Surgery + Radio. (32.6%)
Palliatives (37.9%)
Surgery + Radio. (12.5%)
Surgery (20%)
Surgery (17.2%)
p<0.001
Lingual tonsil
Dorsal face
Border
Ventral face
Contiguous sites
Tongue NOS
Chemo. + Radio. (26.7%)
Surgery (43.2%)
Surgery (55.8%)
Surgery (50%)
Surgery (34.8%)
Surgery (44.1%)
Surgery + Radio. (24.3%)
Surgery + Radio. (16.6%)
Surgery+ Radio. (36.7%)
Surgery + Radio. (30.4%)
Surgery + Radio. (21.1%)
p<0.001
Table 3. First therapeutic option according to studied variables. 
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to that described in other series (4-8). However, in coun-
tries such as India, this mean age decreases to 49.4±11.9 
years (9). The increase in incidence of tongue cancer 
among young males was first observed and reported 
during the 1980s in several analyses undertaken in the 
United States and Europe (10,11), suggesting the poste-
rior evidence that this could be a global problem (12). 
Shiboski et al., using the SEER database between 1973 
and 2001 among white Americans aged 20 to 44 years, 
found a significant increase in SCC incidence, in the 
oral tongue as well as the base of the tongue and palatal 
tonsil. In the remaining oral and pharyngeal sites, its in-
cidence decreased or remained constant (13). Due to the 
absence of habitual risk factors in certain cases of young 
patients, especially among women (14), it has been sug-
gested that oral cancer among them could be a differ-
ent disease than in older patients (15), with a different 
aetiology and progression, which acts in an aggressive 
way (16). However, the relatively anecdotal presence 
of these tumours in young adults and the diversity of 
criteria when selecting a cut-off point for age, location, 
stage and possible aetiology, complicate the compari-
sons between the different studies. Duroux et al. (17) 
consider that the singularity of oral cancer in patients 
under 40 years lies only in the early and massive char-
acter of alcohol-tobacco addiction. Thus, these patients 
could be more likely to reach pathological thresholds 
and develop a tumour of the oral cavity 10 or 20 years 
earlier than the rest of the population.  
Most of the authors report a predominance of tongue 
cancer in men over women (7-9). However, evidence 
shows that this trend is reversing (4,5), probably due 
to behavioural changes among women, although strict 
regulations currently control public smoking in many 
countries, including most of Western Europe.
As in other oral sites, SCC represents the great major-
ity of lingual neoplasms. In our series these neoplasms 
constitute 94.9%, a slightly larger percentage than that 
described by Izarzugaza et al. (91.7%), whose series in-
cluded the base of tongue (18).
With regard to tumour extension, in Bombay 35.2% of 
anterior tongue cancers are diagnosed in early stages, 
43.3% of them are regional and 4% distant stages (19). 
In contrast, the Finnish cancer registry reports that in 
60% of mobile tongue cancers the neoplasm is present 
in localized stages, versus regional (18%) and distant 
(10%) ones. In the period  under study a decrease in the 
proportion of tumours in localized stages is reported. 
This could be due to the fact that the definition of stages 
has changed in the last few decades. Thus, there is an 
observable increase in the number of cases where tu-
mour extension is not specified, which could indicate 
that clinicians have become more careful when classify-
ing a tumour as localized. This could result in an over-
estimation of the increase in survival in early cases, and 
an underestimation in the late ones (4).
When distinguishing between neoplasms affecting the 
anterior and basal areas of tongue, it has been reported 
that 56% of them involve the anterior area (7), where 
the probability of an earlier diagnosis is higher than in 
basal areas (8).
Haddadin et al. (7) and Herranz González-Botas et al. 
(6) regard surgery as the first therapeutic option, thus 
differing from other authors (8) who consider radiother-
apy as the preferred therapy for the management of the 
primary lesion of the mobile tongue. Most of the studies 
in which the type of treatment by age is analysed, con-
centrating on young patients, use surgery as first thera-
peutic option (20). Manuel et al. combine surgery and 
radiotherapy, changing the order of both treatments. In 
the first instance, 36 of their 76 patients younger than 45 
years with SCC of the mobile tongue were treated with 
radiotherapy, and the 40 remaining patients received 
surgery. The 36 patients initially treated with radiother-
apy completed their treatment surgically, 23 of them to 
remove the residual tumour and 13 of them due to loco-
regional failure. On the other hand, 24 of the 40 patients 
initially treated surgically received postoperative radio-
therapy (21). Iype et al. use surgery and radiotherapy in 
equal proportions among their Indian patients young-
er than 35 years of age suffering from mobile tongue 
cancer. It should be noted that chemotherapy was used 
in 20.5% of the cases (22). We observe that histology 
significantly affects the type of treatment employed, as 
even though for both histological groups the preferred 
treatments were surgery and, in the second instance, 
surgery combined with radiotherapy, the “other histolo-
gies” group increases the proportion of chemotherapy, 
palliatives and chemotherapy plus radiotherapy. In our 
results, in line with other authors (8), we observe how 
the kind of treatment applied significantly depends on 
the tumour extension. Thus, localized tumours were ba-
sically surgically treated, while in the regional ones the 
combination of surgery and radiotherapy is chosen. As 
radiotherapy is considered a minimally invasive thera-
peutic procedure, it presents the advantage of preserv-
ing the shape and function of the tongue. 
In conclusion, our population of 610 patients diagnosed 
between 1990 and 2008 with oral tongue cancer in Ma-
drid, presented a mean age of 61.53±13.95 years, the gen-
der ratio being 2.09:1. The lesion was mainly localized 
in the lateral border of the tongue, with predominantly 
squamous cell carcinomas. Most of the cases (59%) ap-
peared in localized stages, versus 35.2% in regional and 
4.8% in distant stages. Surgery was the most frequently 
used treatment, followed by surgery in combination 
with radiotherapy.
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